Tempus AI, Inc. (TEM)
NASDAQ: TEM · Real-Time Price · USD
76.66
+0.33 (0.43%)
At close: Dec 5, 2025, 4:00 PM EST
76.54
-0.12 (-0.16%)
After-hours: Dec 5, 2025, 7:59 PM EST
Tempus AI Revenue
Tempus AI had revenue of $334.21M in the quarter ending September 30, 2025, with 84.72% growth. This brings the company's revenue in the last twelve months to $1.11B, up 72.58% year-over-year. In the year 2024, Tempus AI had annual revenue of $693.40M with 30.38% growth.
Revenue (ttm)
$1.11B
Revenue Growth
+72.58%
P/S Ratio
11.89
Revenue / Employee
$460,524
Employees
2,400
Market Cap
13.64B
Revenue Chart
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| UnitedHealth Group | 435.16B |
| Johnson & Johnson | 92.15B |
| Merck & Co. | 64.24B |
| AbbVie | 59.64B |
| Eli Lilly and Company | 59.42B |
| AstraZeneca | 58.13B |
| Novartis AG | 56.37B |
| Novo Nordisk | 49.58B |
TEM News
- 1 day ago - Is Tempus AI the Next Big Artificial Intelligence Stock to Buy? - The Motley Fool
- 2 days ago - Tempus AI, Inc. (TEM) Presents at Piper Sandler 37th Annual Healthcare Conference Transcript - Seeking Alpha
- 7 days ago - Why Tempus AI Stock Soared This Week - The Motley Fool
- 18 days ago - Tempus to Participate in the Piper Sandler 37th Annual Healthcare Conference - Business Wire
- 21 days ago - Tempus AI: Opportunity To Build Position - Seeking Alpha
- 22 days ago - Tempus and IFLI Announce Study to Advance Follicular Lymphoma Research - Business Wire
- 23 days ago - Tempus AI, Inc. (TEM) Presents at Stifel 2025 Healthcare Conference Transcript - Seeking Alpha
- 23 days ago - Tempus AI: Great Buying Opportunity On Recent Weakness - Seeking Alpha